CHaD pediatrician and associate professor of pediatrics at the Geisel School of Medicine at Dartmouth Susanne E. Tanski, MD, MPH and her coauthors examined the reach of television advertising and its effect on drinking in young people. In 2011 and 2013, they conducted telephone- and web-based surveys with 2,541 adolescents and young adults between the ages of 15 and 23 years at baseline, with 1,596 completing a follow-up survey. The surveys examined recall of more than 300 television advertising images for top beer and distilled spirits brands that aired nationally in 2010-11. The authors derived an alcohol receptivity score based on having seen the ad, liking it and correctly identifying the brand.
“The alcohol industry claims that their advertising self-regulation program protects underage youths from seeing their ads,” said Tanski. “Our study indicates that it does not.” Participants who were underage were only slightly less likely than legal-drinking-age participants to have seen alcohol ads (the average percentage of ads seen were 23.4 percent, 22.7 percent and 25.6 percent, respectively, for young people ages 15-17, 18-20 and 21-23 years of age).
Alcohol is the most common drug used by young people. In 2013, 66.2 percent of U.S. high school students reported trying alcohol, 34.9 percent reported alcohol use in the past 30 days and 20.8 percent reported recent binge drinking. In the U.S. alone, producers of alcohol spend billions of dollars annually marketing their products. And, unlike cigarettes, which voluntarily ended television advertising in 1969, alcohol is actively marketed on television, according to the study background.
Survey results indicate that higher alcohol receptivity score among underage participants predicted the onset of drinking, binge drinking and hazardous drinking in the future. The transition to binge drinking (participants were asked how often they have six or more drinks on one occasion) and hazardous drinking (which was defined as meeting or exceeding a threshold score for frequency and quantity of alcohol use) happened for 29 percent and 18 percent of young people ages 15 to 17 years, respectively, and for 29 percent and 19 percent of young people ages 18 to 20 years, respectively.
“Alcohol companies claim their advertising does not affect underage drinking – that instead it is parents and friends that are the culprits,” said James D. Sargent, MD, senior author on the study and a CHaD pediatrician, the Scott M. and Lisa G. Stuart Professor of Pediatric Oncology at Geisel, and co-director of the NCCC Cancer Control Program. “This study suggests otherwise – that underage youths are exposed to and engaged by alcohol marketing and this prompts initiation of drinking as well as transitions from trying to hazardous drinking.”
“Our study found that familiarity with and response to images of television alcohol marketing was associated with the subsequent onset of drinking across a range of outcomes of varying severity among adolescents and young adults, adding to studies suggesting that alcohol advertising is one cause of youth drinking,” the authors conclude. “Current self-regulatory standards for televised alcohol advertising appear to inadequately protect underage youth from exposure to televised alcohol advertising and its probable effect on behavior.”
Editor’s Note: The research is the result of a National Institutes of Health-funded collaboration between pediatric scientists at Geisel School of Medicine and social neuroscientists at Psychological and Brain Sciences at Dartmouth College, to better understand the mechanisms through which alcohol marketing affects underage drinking behaviors. The full article can be read in the January 19 issue of JAMA Pediatrics, at http://archpedi.jamanetwork.com/article.aspx?doi=10.1001/jamapediatrics.2014.3345 Please see article for additional information, including other authors, author contributions and affiliations, etc.
Dartmouth-Hitchcock (D-H) is a nonprofit academic health system that serves a patient population of 1.2 million in New England. In addition to CHaD and the NCCC, , the system includes; affiliate hospitals in New London, NH, and Windsor, VT; and 24 Dartmouth-Hitchcock Clinics that provide ambulatory services across New Hampshire and Vermont, all anchored by Dartmouth-Hitchcock Medical Center in Lebanon, NH. D-H provides access to more than 1,000 primary care doctors and specialists in almost every area of medicine. In partnership with the Audrey and Theodor Geisel School of Medicine at Dartmouth and the White River Junction VA Medical Center in White River Junction, VT, it trains nearly 400 residents and fellows annually, and performs world-class research.
As New Hampshire’s full service, comprehensive children’s hospital, the Children’s Hospital at Dartmouth-Hitchcock (CHaD) is committed to providing outstanding compassionate care for children and their families. Their physician expertise provides primary, specialty, and tertiary care to the children of New Hampshire, Vermont, and beyond, as northern New England’s children’s hospital. CHaD offers both inpatient and outpatient services at Dartmouth-Hitchcock Medical Center in Lebanon, NH. Outpatient and same day surgery services are available at Dartmouth-Hitchcock Manchester, as well as outpatient pediatric specialties at Wentworth-Douglass Hospital, Dover. Primary care is available at Dartmouth-Hitchcock facilities in Bedford, Concord, Keene, Lebanon, Manchester, Nashua, New London, and Plymouth, NH, and in Bennington, VT.
About Norris Cotton Cancer Center
Norris Cotton Cancer Center combines advanced cancer research at Dartmouth and the Geisel School of Medicine with patient-centered cancer care provided at Dartmouth-Hitchcock Medical Center, at Dartmouth-Hitchcock regional locations in Manchester, Nashua, and Keene, NH, and St. Johnsbury, VT, and at 12 partner hospitals throughout New Hampshire and Vermont. It is one of 41 centers nationwide to earn the National Cancer Institute’s “Comprehensive Cancer Center” designation. Learn more about Norris Cotton Cancer Center research, programs, and clinical trials online at cancer.dartmouth.edu.